Physician profile

Daryl J Gasca

Periodontics · Glenwood Springs, CO

NPI 1992129456

$2,809.87

in general payments reported to CMS, 2019-2025

7 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$1,002.40
Entertainment$482.85
Education$159.60

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Ivoclar Vivadent, INC. $1,422.37 2022-2024
Nobel Biocare USA $851.13 2019-2023 Nobelactive
Keystone Dental INC. $209.81 2023
Hu-Friedy Mfg. Co., LLC $149.93 2021-2023 Ims
Zimvie INC. $106.29 2024
Envista Holdings Corporation $48.53 2024 Biomaterials
Kerr Corporation $21.81 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Daryl J Gasca

$2,809.87

in general payments reported 2019-2025

Years
2019-2024
Top company
Ivoclar Vivadent, INC.

https://glasscript.com/doctor/90243/daryl-j-gasca

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.